Price $465.15 |
Market Cap
185.7B
|
Sector Health Care |
Div. Growth
15.80%
|
|
P/E
23.6
|
P/B
5.28
|
P/S
5.15
|
Dividend %
0.20%
|
|
P/CF
72.7
|
P/FCF
24.3
|
Op. Cash Flow
9.91M
|
FCF
19.3
|
|
Op. Margin
27.70%
|
Net Margin
22.10%
|
ROE
24.10%
|
ROI
12.30%
|
|
ROA
12.20%
|
EPS Growth
118.30%
|
Current Ratio
2.1
|
Debt/Equity
55.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $5.96 | - | - | 1.68B | Strong Buy |
| Acer Therapeutics Inc (ACER) | $3.10 | - | - | 42.4M | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.82 | - | - | 80.8M | Strong Buy |
| Precision Optics Corporation I (PEYE) | $1.58 | - | - | 22.5M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $67.34 | - | 3.00% | 146.72B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
